Tekla Life Sciences Investors
- HQL
- NYSE
- Asset Management
- Life Sciences Investment Fund
$17.03
Today +1.49%Quote Oct 19, 2026, 08:00 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
−12.26%over the last month
Max drawdown −16.0%From 1-month high −14.8%3 months −14.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Tekla Life Sciences Investors
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide.
Sector
Financial services
Industry
Asset Management
Exchange
NYSE
Market value
$517.8M
Quote Oct 19
Floor
$16.23
4.7% below price
Resistance
$17.06
0.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HQLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free